Leslie Lauersdorf, ARNP

Moffitt Cancer Center
Tampa Bay, Florida
Authored Items
Keeping Up to Date on New Multiple Myeloma Drugs
Leslie Lauersdorf, ARNP
Conference Correspondent  in Hematologic Cancers, Conference Correspondent, ASH
Caring for Patients with Relapsed/Refractory Multiple Myeloma
Leslie Lauersdorf, ARNP
Conference Correspondent  in Hematologic Cancers, Conference Correspondent, ASH
Educating Your Patients About Daratumumab
Leslie Lauersdorf, ARNP
Conference Correspondent  in Hematologic Cancers, Conference Correspondent, ASH
Patient Education is Crucial
Leslie Lauersdorf, ARNP
Conference Correspondent  in Hematologic Cancers, Conference Correspondent, ASH
How Patients Can Help with Side Effect Management
Leslie Lauersdorf, ARNP
Conference Correspondent  in Hematologic Cancers, Conference Correspondent, ASH
New Therapies to Treat Multiple Myeloma
Leslie Lauersdorf, ARNP
Conference Correspondent  in Hematologic Cancers, Conference Correspondent, ASH
The Importance of Survivorsihp Care in Mutliple Myeloma
Leslie Lauersdorf, ARNP
Conference Correspondent  in Hematologic Cancers, Conference Correspondent, ASH
A Look at Daratumumab
Leslie Lauersdorf, ARNP
Conference Correspondent  in Conference Correspondent, ASH
Daratumumab: What Patients Want to Know
Leslie Lauersdorf, ARNP
Conference Correspondent  in Conference Correspondent, ASH
Managing Treatment-Related Toxicities
Leslie Lauersdorf, ARNP
Conference Correspondent  in Conference Correspondent, ASH
The Janssen CarePath Program and the Cost of Care
Leslie Lauersdorf, ARNP
Conference Correspondent  in Conference Correspondent, ASH
Last modified: December 4, 2016